Evidence map›Paper›PMID 36941300›Full record

ArticleNature communications2023

Author Correction: Repeated out-of-Africa expansions of Helicobacter pylori driven by replacement of deleterious mutations.

Harry A Thorpe, Elise Tourrette, Koji Yahara, Filipa F Vale, Siqi Liu, Mónica Oleastro, Teresa Alarcon, Tsachi-Tsadok Perets, Saeid Latifi-Navid, Yoshio Yamaoka and 14 more

Full text readPublished Erratum
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Harry A Thorpe *Department of Biostatistics, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0001-5895-3232
Elise Tourrette *CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
Koji Yahara *Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.ORCID http://orcid.org/0000-0003-4289-1115
Filipa F ValePathogen Genome Bioinformatics and Computational Biology, Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.ORCID http://orcid.org/0000-0003-4635-0105
Siqi LiuCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
Mónica OleastroNational Reference Laboratory for Gastrointestinal Infections, Department of Infectious Diseases, National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.ORCID http://orcid.org/0000-0001-6360-2576
Teresa AlarconDepartment of Microbiology, Hospital Universitario La Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain.
Tsachi-Tsadok PeretsGastroenterology Laboratory, Rabin Medical Center, Petah Tikva, Israel.
Saeid Latifi-NavidDepartment of Biology, Faculty of Sciences, University of Mohaghegh Ardabili, Ardabil, Iran.ORCID http://orcid.org/0000-0002-6838-9425
Yoshio YamaokaDepartment of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Yufu, Oita, Japan.ORCID http://orcid.org/0000-0002-1222-5819
Beatriz Martinez-GonzalezLaboratory of Medical Microbiology, Hellenic Pasteur Institute, Athens, Greece.
Ioannis KarayiannisLaboratory of Medical Microbiology, Hellenic Pasteur Institute, Athens, Greece.
Timokratis KaramitrosLaboratory of Medical Microbiology, Hellenic Pasteur Institute, Athens, Greece.
Dionyssios N SgourasLaboratory of Medical Microbiology, Hellenic Pasteur Institute, Athens, Greece.ORCID http://orcid.org/0000-0003-0975-2607
Wael ElaminG42 Healthcare, Abu Dhabi, UAE.ORCID http://orcid.org/0000-0003-2590-6274
Ben PascoeDepartment of Biology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-6376-5121
Samuel K SheppardIneos Oxford Institute, Department of Biology, University of Oxford, Oxford, UK.
Jukka RonkainenCenter for Life Course Health Research, University of Oulu, Oulu, Finland.ORCID http://orcid.org/0000-0002-5335-8677
Pertti AroArokero Oy, Tornio, Finland.ORCID http://orcid.org/0000-0001-5681-0852
Lars EngstrandCenter for Translational Microbiome Research, Department for Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Lars AgreusDivision of Family Medicine, Karolinska Institutet, Stockholm, Sweden.
Sebastian SuerbaumDepartment of Medical Microbiology and Hospital Epidemiology, Max von Pettenkofer Institute, Faculty of Medicine, LMU Munich, Munich, Germany.ORCID http://orcid.org/0000-0001-9583-7505
Kaisa ThorellInstitute of Biomedicine, Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden.
Daniel FalushCAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China. danielfalush@googlemail.com.ORCID http://orcid.org/0000-0002-2956-0795

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36941300
PMCPMC10027682

What OpenQuestion holds

Textfull text, public
LicenceCC BY
identifiers read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.